Allspring Global Investments Holdings LLC lessened its position in Maximus, Inc. (NYSE:MMS - Free Report) by 17.0% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 599,578 shares of the health services provider's stock after selling 122,594 shares during the period. Allspring Global Investments Holdings LLC owned approximately 1.06% of Maximus worth $41,179,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Captrust Financial Advisors acquired a new stake in Maximus during the 4th quarter worth about $276,000. IFP Advisors Inc increased its stake in shares of Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after purchasing an additional 302 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Maximus by 7.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock valued at $74,700,000 after purchasing an additional 71,598 shares in the last quarter. Blue Trust Inc. lifted its stake in shares of Maximus by 32.8% in the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after purchasing an additional 303 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in Maximus by 8.2% in the fourth quarter. Bank of New York Mellon Corp now owns 570,740 shares of the health services provider's stock worth $42,606,000 after purchasing an additional 43,421 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In related news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction on Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the sale, the director owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.60% of the stock is owned by company insiders.
Analyst Ratings Changes
Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.
Read Our Latest Stock Report on MMS
Maximus Price Performance
Shares of Maximus stock traded down $0.38 during trading on Friday, hitting $72.06. 224,629 shares of the company's stock traded hands, compared to its average volume of 572,343. The company has a market cap of $4.06 billion, a PE ratio of 14.33 and a beta of 0.61. The firm's fifty day moving average price is $71.09 and its 200 day moving average price is $70.94. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.84 and a quick ratio of 1.84.
Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. The company had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a net margin of 5.56% and a return on equity of 23.37%. Maximus's quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.57 earnings per share. Analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.
Maximus Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th were given a dividend of $0.30 per share. The ex-dividend date was Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.67%. Maximus's dividend payout ratio is 23.86%.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.